Detalles de la búsqueda
1.
A Vulnerability of a Subset of Colon Cancers with Potential Clinical Utility.
Cell
; 165(2): 317-30, 2016 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27058664
2.
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions.
Genome Res
; 34(4): 539-555, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38719469
3.
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study.
Cancer
; 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38752572
4.
Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.
BMC Med
; 22(1): 9, 2024 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38191387
5.
De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1-2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07).
Br J Surg
; 111(4)2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38597154
6.
Multiscale deep learning framework captures systemic immune features in lymph nodes predictive of triple negative breast cancer outcome in large-scale studies.
J Pathol
; 260(4): 376-389, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37230111
7.
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
JAMA
; 331(13): 1135-1144, 2024 04 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38563834
8.
High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation.
BMC Cancer
; 23(1): 26, 2023 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36611165
9.
De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03): 5-year follow-up results of a Dutch, prospective, registry study.
Lancet Oncol
; 23(9): 1201-1210, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35952707
10.
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial.
Int J Cancer
; 151(8): 1394-1404, 2022 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35583992
11.
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients.
Br J Cancer
; 126(10): 1401-1409, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35124703
12.
Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols.
Hum Reprod
; 37(8): 1786-1794, 2022 07 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35776109
13.
Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017.
Int J Cancer
; 148(9): 2289-2303, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33252836
14.
A Phase I dose-escalation study of two cycles carboplatin-olaparib followed by olaparib monotherapy in patients with advanced cancer.
Int J Cancer
; 148(12): 3041-3050, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33539540
15.
Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer.
Breast Cancer Res Treat
; 185(3): 817-830, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33113088
16.
BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer.
Breast Cancer Res
; 22(1): 79, 2020 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32711554
17.
IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer.
Int J Cancer
; 146(8): 2348-2359, 2020 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31490549
18.
Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial.
Breast Cancer Res Treat
; 180(3): 675-685, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32124136
19.
Contralateral parenchymal enhancement on breast MRI before and during neoadjuvant endocrine therapy in relation to the preoperative endocrine prognostic index.
Eur Radiol
; 30(12): 6740-6748, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32691100
20.
Estrogen receptor α wields treatment-specific enhancers between morphologically similar endometrial tumors.
Proc Natl Acad Sci U S A
; 114(8): E1316-E1325, 2017 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28167798